Abstract
Purpose
With advancements in detection and treatment, the number of breast cancer survivors is growing. To reduce mortality among survivors, tailored health-promotion programs are needed to combat comorbidities. However, the demand for such programs exceed that which is available for a vastly diverse population of survivors. The goal of the present study was to describe the prevalence of comorbidities in a group of breast cancer survivors and to examine associations between biological proximal factors of and the more distal individual-level factors on the number and types of comorbidities.
Methods
In addition to medical chart reviews, breast cancer survivors (N = 369) from hospitals in two urban locations completed self-report measures. Bivariate analyses examined the relationship between distal and proximal predictors and the outcomes: number of comorbidities and comorbidity types.
Results
Both proximal and distal factors were associated with comorbidities. African American, women with lower education attainment, and older women were more likely to be obese and have more comorbidities than their counterparts. In particular, they were more at risk for cardiovascular disease. Those who initiated hormonal therapy, chemotherapy, and radiation therapy were more likely to have comorbidities. Several psychosocial variables were related to proximal psychosocial factors.
Conclusions
The present findings highlight the need for targeted health-promotion treatments for breast cancer survivors, particularly for African Americans, those with lower education attainment, those who are obese, and those who may be older. Given the relationships between specific comorbidities and proximal psychosocial factors, future interventions may benefit from tailored approaches.
Implications for cancer survivors
Tailored interventions for survivors may be more effective when accounting for factors associated with health-promotion engagement.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: Cancer J Clin 62(1):10–29
Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol: Off J Am Soc Clin Oncol 23(24):5814–5830
La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B (2011) Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist 16(6):726–729
Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344(26):1997–2008
Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R (2009) Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv: Res Pract 3(2):89–98
Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105(18):1344–1354
Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA: J Am Med Assoc 294(14):1765–1772
Louwman WJ, Aarts MJ, Houterman S, van Lenthe FJ, Coebergh JW, Janssen-Heijnen ML (2010) A 50 % higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 103(11):1742–1748
Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111
Ording AG, Garne JP, Nystrom PM, Froslev T, Sorensen HT, Lash TL (2013) Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis—a Danish nationwide matched cohort study. PLoS ONE 8(10):e76013
Dehal A, Abbas A, Johna S (2013) Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database. Breast Cancer Res Treat 139(2):469–476
Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, Armstrong K (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol: Off J Am Soc Clin Oncol 27(6):933–938
Mosher CE, Lipkus I, Sloane R, Snyder DC, Lobach DF, Demark-Wahnefried W (2013) Long-term outcomes of the FRESH START trial: exploring the role of self-efficacy in cancer survivors’ maintenance of dietary practices and physical activity. Psycho-Oncology 22(4):876–885
Lewis N, Martinez LS, Freres DR, Schwartz JS, Armstrong K, Gray SW, Fraze T, Nagler RH, Bourgoin A, Hornik RC (2012) Seeking cancer-related information from media and family/friends increases fruit and vegetable consumption among cancer patients. Health Commun 27(4):380–388
Sheppard VB, Isaacs C, Luta G, Willey SC, Boisvert M, Harper FW, Smith K, Horton S, Liu MC, Jennings Y et al (2013) Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship. Breast Cancer Res Treat 139(1):207–216
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression scale. An updated literature review. J Psychosom Res 52(2):69–77
Wolf MS, Chang CH, Davis T, Makoul G (2005) Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns 57(3):333–341
Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE (1998) The primary care assessment survey: tests of data quality and measurement performance. Med Care 36(5):728–739
Rutten LF, Moser RP, Beckjord EB, Hesse BW, Cryle RT (2007) Cancer communication: health information national trends survey. In: Edited by Institute NC. Washington, DC
Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C (1991) Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 32(1):35–42
Degner LF, Sloan JA, Venkatesh P (1997) The Control Preferences scale. Can J Nurs Res Revue Can de Recherche Sci Infirm 29(3):21–43
DiMatteo MR, Hays RD, Sherbourne CD (1992) Adherence to cancer regimens: implications for treating the older patient. Oncology (Williston Park) 6(2 Suppl):50–57
Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH (2011) Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 20(10):1996–2005
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA: Cancer J Clin 54(2):78–93
Ashing K, Rosales M, Lai L, Hurria A: Occurrence of comorbidities among African-American and Latina breast cancer survivors. J Cancer Surviv: Res Pract 2014
Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP (2012) Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer 118(16):4024–4031
Rowland JH, Bellizzi KM (2008) Cancer survivors and survivorship research: a reflection on today’s successes and tomorrow’s challenges. Hematol/Oncol Clin North Am 22(2):181–200, v
Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(9):972–977
Sheppard VB, Hicks J, Dennis Parker EA, Makambi K, Hurtado-de-Mendoza A, Lucas W, Demark-Wahnefried W, Adams-Campbell L (2013) Lessons learned from the Stepping STONE Feasibility Trial: improving exercise and diet behaviors in overweight and obese black breast cancer survivors. American Association for Cancer Education, Seattle, WA
Acknowledgments
This work was funded in part by grants from the American Cancer Society (Sheppard: PI MRSGT-06-132 CPPB), Komen for the Cure, Inc. (PI: Sheppard POP0503398), and the National Cancer Institute (Mandelblatt: RO1 CA124924, RO1 CA 127617, and KO5 CA96940).
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Conflicts of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Highland completed the present manuscript while at the Cancer Prevention Control Program at Georgetown University Medical Center.
Rights and permissions
About this article
Cite this article
Highland, K.B., Hurtado-de-Mendoza, A., Stanton, C.A. et al. Risk-reduction opportunities in breast cancer survivors: capitalizing on teachable moments. Support Care Cancer 23, 933–941 (2015). https://doi.org/10.1007/s00520-014-2441-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2441-7